<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03112434</url>
  </required_header>
  <id_info>
    <org_study_id>2016-628</org_study_id>
    <nct_id>NCT03112434</nct_id>
  </id_info>
  <brief_title>Muscle Elastography in Spastic Cerebral Palsy</brief_title>
  <official_title>Use of Elastography to Quantify Change in Upper Extremity Muscle Spasticity Following Botox Injection in Children With Spastic Cerebral Palsy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital for Special Surgery, New York</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Radiological Society of North America</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital for Special Surgery, New York</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To date, clinical tests are unable to differentiate between the cause of muscle stiffness,&#xD;
      although a manual instrumented spasticity assessment for the lower limb that utilizes surface&#xD;
      electromyogram has recently been proposed. This study intends to use shear wave elastography&#xD;
      to assess individual muscle stiffness parameters and the individual response to botulinum&#xD;
      toxin injection in the elbow and wrist flexors. Collection of baseline spasticity parameters&#xD;
      could then be used to predict the effect of botulinum toxin type A and ultimately serve as a&#xD;
      basis for development of a treatment model for muscle spasticity in patients with spastic&#xD;
      cerebral palsy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">December 14, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Muscle Elasticity</measure>
    <time_frame>From immediate pre-injection to 1 month post-injection.</time_frame>
    <description>Change in muscle elasticity (in kilopascal )</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Muscle Elasticity</measure>
    <time_frame>From immediate pre-injection to 1 month post-injection.</time_frame>
    <description>Change in muscle elasticity (in m/s)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional measures</measure>
    <time_frame>immediately pre- and immediately post-injection, and at 1 month, 3 months and 6 months post-injection.</time_frame>
    <description>Functional measures (MAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional measures</measure>
    <time_frame>immediately pre- and immediately post-injection, and at 1 month, 3 months and 6 months post-injection.</time_frame>
    <description>Functional measures (PROM)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Unilateral Spastic Cerebral Palsy</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Botulinum toxin type A</intervention_name>
    <description>Botox injection in upper extremity for spasticity in pediatric CP patients</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with unilateral spastic CP with presence of dynamic muscle spasticity in the elbow&#xD;
        and/or wrist flexors, who will be able to provide consent. Consent may be obtained from a&#xD;
        parent or legal guardian, as applicable.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with unilateral spastic cerebral palsy with presence of dynamic muscle&#xD;
             spasticity in the elbow and/or wrist flexors, who will be able to provide consent.&#xD;
&#xD;
          -  Consent may be obtained from a parent or legal guardian, as applicable.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Prior surgical procedure in the affected upper extremity&#xD;
&#xD;
          -  Unrelated orthopedic injury to the affected upper extremity&#xD;
&#xD;
          -  Current oral or intrathecal antispasticity therapy&#xD;
&#xD;
          -  Prior Botulinum toxin type A injection in preceding 6 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital for Special Surgery</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>April 3, 2017</study_first_submitted>
  <study_first_submitted_qc>April 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 13, 2017</study_first_posted>
  <last_update_submitted>August 9, 2021</last_update_submitted>
  <last_update_submitted_qc>August 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Spasticity</mesh_term>
    <mesh_term>Cerebral Palsy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Botulinum Toxins</mesh_term>
    <mesh_term>Botulinum Toxins, Type A</mesh_term>
    <mesh_term>abobotulinumtoxinA</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

